Thoracoscopic pulmonary vein isolation after previous percutaneous atrial septal defect closure

Noriyuki Matsutani1, Richard Lee, Jennifer O'Leary

  • 1Department of Surgery II, National Defense Medical College, Namiki, Tokorozawa, Saitama, Japan.

Journal of Cardiac Surgery
|September 17, 2008
PubMed

Insights

Atrial fibrillation (AF) is common in older adults with atrial septal defect (ASD). Thoracoscopic pulmonary vein isolation offers a minimally invasive option for AF treatment in patients with existing ASD closure devices.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Electrophysiology

Background:

  • Atrial fibrillation (AF) is a significant cause of morbidity in patients over 40 with atrial septal defect (ASD).
  • Conventional atrial septal defect closure may preclude future transseptal catheter interventions.
  • Surgical epicardial pulmonary vein isolation is effective for AF treatment.

Observation:

  • This case report details a thoracoscopic-assisted pulmonary vein isolation procedure.
  • The patient had a pre-existing atrial septal occlusion device.
  • This approach was utilized in a minimally invasive manner via bilateral thoracotomies.

Findings:

  • Thoracoscopic-assisted pulmonary vein isolation is a feasible technique in patients with prior atrial septal occlusion devices.
  • This minimally invasive approach provides an alternative for AF management in this specific patient population.

Implications:

  • This technique may preserve future transseptal access options.
  • Minimally invasive epicardial ablation offers a viable strategy for AF treatment in patients with ASD devices.
  • Further research is warranted to evaluate long-term outcomes.